Drugs / rgp120/HIV-1SF2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001046 | — | HIV infectious disease, pregnancy disorder | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rgp120/HIV-1SF2 | “Women are randomized to receive rgp120/HIV-1SF2 vaccine or MF59 placebo.” NCT00001046 ↗ |
| Modality | Vaccine | “rgp120/HIV-1SF2 vaccine” NCT00001046 ↗ |